A phase I first‐in‐human study with tefinostat – a monocyte/macrophage targeted histone deacetylase inhibitor – in patients with advanced haematological malignancies

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|162|2|191-201

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.162, Iss.2, 2013-07, pp. : 191-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : 1223-1230

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐in‐human trial of the PI3Kβ‐selective inhibitor SAR260301 in patients with advanced solid tumors

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 315-324

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignancies

By Awada Ahmad   Zhang Steven   Gil Thierry   de Valeriola Dominique   Lalami Yassine   De Porre Peter   Piccart-Gebhart Martine J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 991-1003

Informa Healthcare

Access to resources Recommend Favorite

A Phase I Study of the Optimized Cryptic Peptide TERT572Y in Patients with Advanced Malignancies

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 306-314

Karger

Access to resources Recommend Favorite

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination with Oral Vinorelbine in Patients with Advanced Solid Malignancies

By  

Oncology Research and Treatment, Vol. 36, Iss. 1-2, 2013-01 ,pp. : 40-45

Karger

Access to resources Recommend Favorite